Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. [electronic resource]
- Human immunology May 2003
- 497-504 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0198-8859
10.1016/s0198-8859(03)00041-7 doi
Antiviral Agents--therapeutic use CD4-Positive T-Lymphocytes--drug effects CD8-Positive T-Lymphocytes--drug effects Drug Therapy, Combination Enzyme-Linked Immunosorbent Assay Epitopes Hepacivirus--drug effects Hepatitis C, Chronic--drug therapy Humans Interferon-alpha--therapeutic use Male Middle Aged Prospective Studies Ribavirin--therapeutic use Time Factors Treatment Outcome Viral Load